The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
AI-powered quantification of tumor-infiltrating lymphocytes from H&E stained images in ovarian cancer and its association with PARP inhibitor therapy outcomes.
 
Hiroshi Asano
No Relationships to Disclose
 
Kanako Hatanaka
Honoraria - AstraZeneca; Daiichi Sankyo (I); Lilly; Merck (I); MSD oncology (I)
Speakers' Bureau - AstraZeneca; Chugai Pharma; Sakura Finetek Japan
Research Funding - Sakura Finetek Japan; Sekisui Medical
Travel, Accommodations, Expenses - AstraZeneca; Chugai Pharma
 
Takuma Kobayashi
Employment - Biomy
 
Teppei Konishi
Leadership - Biomy
 
Hiroyuki Kurosu
No Relationships to Disclose
 
Hiroko Matsumiya
No Relationships to Disclose
 
Yoshiki Shinomiya
No Relationships to Disclose
 
Ryo Matoba
Leadership - DNA Chip Research
Stock and Other Ownership Interests - DNA Chip Research
 
Daisuke Komura
No Relationships to Disclose
 
Shumpei Ishikawa
No Relationships to Disclose
 
Shinya Tanaka
No Relationships to Disclose
 
Hidemichi Watari
Honoraria - AstraZeneca; Takeda
Research Funding - Chugai Pharma; Hokkaido Cancer Society; Hokkaido Welfare Federation of Agricultural Corporatives; Kaken Pharmaceutical; Mochida Pharmaceutical Co. Ltd.; Taiho Pharmaceutical
Other Relationship - T-PEC
 
Yutaka Hatanaka
Honoraria - AstraZeneca; Daiichi Sankyo; Lilly; Merck; MSD Oncology
Speakers' Bureau - AstraZeneca
Research Funding - CURED; Daiichi Sankyo; Konica Minolta REALM; Lilly; NEC Corporation